Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price Rises 5% Today; Stock News, Valuation and Sector View

Published: 22 September 2026 at 11:48:25 AM IST

Sudeep Pharma Share Price moved higher today, closing at Rs 1,201.50 after a 5% rise from the previous close of Rs 1,144.30. The stock added Rs 57.20 during the session, with market capitalisation at Rs 13,045 crore. The day’s range ran from Rs 1,108.20 to Rs 1,201.50, and turnover stood at Rs 2.15 crore. This Sudeep Pharma Share Price move places the stock among the notable Sudeep Pharma Share Price Today updates in healthcare market news, even though the supplied data does not establish a company-specific catalyst. Univest is tracking the event as a factual price rise, and investors can next monitor valuation, sector comparison and any fresh company disclosures that may explain the move later.

In Sudeep Pharma Stock News, the key point is that the stock rose from a weaker open than its close and finished at the day’s high. That price behaviour confirms a clear same-day gain, but the available figures alone do not identify why the move occurred. For readers searching Sudeep Pharma Share Price Today, the most useful context is the company’s current market value, profitability ratios and premium valuation versus industry peers. Univest places that mix of price action and fundamentals in one view so the event can be read as both a share price rise and a stock analysis update.

Sudeep Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,201.5
Previous Close	Rs 1,144.3
Today's Move	Rs 57.2 (+5%)
Open	Rs 1,108.2
High	Rs 1,201.5
Low	Rs 1,108.2
Turnover	Rs 2.15 crore
Market Capitalisation	Rs 13,045 crore
Market Cap Category	Mid Cap

Sudeep Pharma Ltd. (SUDEEPPHRM) rose to Rs 1,201.5 from the previous close of Rs 1,144.3, a move of Rs 57.2 or 5%. The stock opened at Rs 1,108.2, reached a high of Rs 1,201.5, recorded a low of Rs 1,108.2.

Sudeep Pharma Share Price Today shows a straightforward same-day rise: the stock opened at Rs 1,108.20, touched Rs 1,201.50 during the session, and closed at Rs 1,201.50 after gaining Rs 57.20, or 5%, versus the previous close of Rs 1,144.30. The closing price matching the day’s high indicates that the session ended at its best available level, while the low of Rs 1,108.20 marks the session floor. Turnover of Rs 2.15 crore gives a factual traded-value reference, but the supplied data does not establish a company-specific catalyst behind the move. For Sudeep Pharma Share Price readers, this is the cleanest summary of what happened today.

The same figures also explain why Sudeep Pharma Share Price is appearing in stock updates and Top Gainers Today searches. It was not a marginal drift; the move was Rs 57.20 on the day, which is meaningful relative to the previous close. Still, the article remains grounded in verified data only: the Sudeep Pharma Share Price rise is confirmed, and the cause is not confirmed by the supplied dataset.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 13,045 crore
P/E Ratio	70.77x
P/B Ratio	13.99x
ROE	25.37%
ROCE	28.5%
EPS	Rs 16.17
Book Value Per Share	Rs 81.8
Dividend Yield	0.13%

Sudeep Pharma Ltd. (SUDEEPPHRM) fundamental metrics show P/E 70.77x, P/B 13.99x, ROE 25.37%, ROCE 28.5%. These figures provide context only and are not a buy or sell signal.

Sudeep Pharma Ltd. has a market capitalisation of Rs 13045 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 70.77x, P/B at 13.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.37% and ROCE of 28.5%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 16.17, book value per share of Rs 81.8, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	70.77x
Benchmark Median P/E	32.62x
Benchmark Average P/E	49.51x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	13.99x
Benchmark Median P/B	3x
Company ROE	25.37%
Benchmark Median ROE	11.74%
Company ROCE	28.5%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 13,045 crore
Benchmark Median Market Cap	Rs 746.45 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 70.77x, which is above the benchmark median of 32.62x, a difference of +116.95%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 25.37%, which is above the benchmark median of 11.74%, a difference of +116.1%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 28.5%, which is above the benchmark median of 13.63%, a difference of +109.1%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	37.05	5.18	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.6	14.18	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	86.64	21.05	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.67	4.3	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	33.19	3.18	11.83	16

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 70.77x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.37% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 28.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 13,045 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma

• Sudeep Pharma Share Price rose 5% today to Rs 1,201.50, with a gain of Rs 57.20 over the previous close.
• Market capitalisation stands at Rs 13,045 crore, placing the company above the industry median market value in the supplied benchmark.
• P/E is 70.77 and P/B is 13.99, both above the same-industry median and average.
• ROE is 25.37 and ROCE is 28.5, both above the benchmark median and average for the industry set.
• Turnover was Rs 2.15 crore, and the stock ended at its day high of Rs 1,201.50.

About Sudeep Pharma

Sudeep Pharma operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. The supplied dataset does not provide a segment split or product list, so the company should be read here through the verified financial and market structure only. Even within that limited company description, the Sudeep Pharma Share Price context is useful because the business sits in a sector where valuation, profitability and peer comparison are central to market perception.

What can be stated from the available facts is that the company is valued at Rs 13,045 crore and trades on a P/E of 70.77, P/B of 13.99, ROE of 25.37 and ROCE of 28.5. EPS is Rs 16.17, book value is Rs 81.8 and dividend yield is 0.13. Those figures give readers a compact company overview for Sudeep Pharma Share Price, Sudeep Pharma Stock News and Sudeep Pharma Stock Analysis searches, without extending beyond the supplied data.

Track Sudeep Pharma Share Price on Univest

Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Sudeep Pharma Share Price on Univest for live share price updates, valuation ratios, company financials, shareholding pattern, 52-week levels and market insights. Univest also keeps the broader Sudeep Pharma Share Price Today context together with Sudeep Pharma Fundamental Analysis and related stock details for quick review.

For investors comparing Sudeep Pharma Share Price with other healthcare names, Univest brings together the same set of company and sector figures used in this article. That makes it easier to revisit Sudeep Pharma Share Price News, monitor company updates and review the stock alongside the wider Indian stock market conversation.

Frequently Asked Questions

Why did Sudeep Pharma Share Price rise today?

Ans. The dataset confirms a 5% same-day rise to Rs 1,201.50, but it does not establish a company-specific catalyst. The verified facts show the price action, opening range, close and turnover only.

What is Sudeep Pharma Share Price today?

Ans. Sudeep Pharma Share Price today is Rs 1,201.50. It rose Rs 57.20, or 5%, from the previous close of Rs 1,144.30 and finished at the day’s high. The previous close was Rs 1,144.3.

What is Sudeep Pharma’s market capitalisation?

Ans. Sudeep Pharma’s market capitalisation is Rs 13,045 crore. In the same-industry benchmark, that figure is above the median market capitalisation but below the benchmark average. The company operates in the Healthcare sector.

How does Sudeep Pharma look on valuation?

Ans. The stock trades at a P/E of 70.77 and a P/B of 13.99. Both ratios are above the same-industry median and average, which places the valuation on the richer side of the peer set.

What do Sudeep Pharma’s ROE and ROCE show?

Ans. ROE is 25.37 and ROCE is 28.5. Both are above the same-industry median and average, which gives useful profitability context for Sudeep Pharma Share Price and Sudeep Pharma Stock News.

What are Sudeep Pharma’s EPS and book value?

Ans. EPS is Rs 16.17 and book value is Rs 81.8. EPS shows earnings attributable to each share, while book value shows accounting net worth per share at the current Sudeep Pharma Share Price.

How does Sudeep Pharma compare with peers?

Ans. Sudeep Pharma’s P/E is higher than Sun Pharma, Zydus Lifesciences, Cipla and Aurobindo Pharma, but lower than Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs. Its ROCE is among the stronger readings in the set.

What sector does Sudeep Pharma operate in?

Ans. Sudeep Pharma operates in Healthcare, within the Pharmaceuticals & Drugs industry. The supplied benchmark covers 200 same-industry companies, which helps place the Sudeep Pharma Share Price in context. The stock belongs to the Healthcare sector.